PHENURONE Drug Patent Profile
✉ Email this page to a colleague
When do Phenurone patents expire, and when can generic versions of Phenurone launch?
Phenurone is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in PHENURONE is phenacemide. Additional details are available on the phenacemide profile page.
Summary for PHENURONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Patent Applications: | 2,959 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHENURONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PHENURONE
US Patents and Regulatory Information for PHENURONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | PHENURONE | phenacemide | TABLET;ORAL | 007707-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |